Global bi-Hamiltonian structure of three dimensional dynamical systems
2016
0 görüntülenme
0 i̇ndirme
Danışman: Doç. Dr. Ender Abadoğlu
Özet (EN)
In this thesis the conditions for the local existence of the bi-Hamiltonian structure corresponding to a non-vanishing vector field on three dimensional manifolds are obtained by using the given vector field alone. It is shown that any non-vanishing vector field on a three dimensional manifold is locally bi-Hamiltonian. Then by working on the equations related with the local existence, the obstructions to extension of local bi-Hamiltonian structure are obtained. After that, these obstructions are expressed in terms of the characteristic classes related with the normal bundle of the given vector field. It is shown that any non-vanishing vector field on a three dimensional manifold is globally bi-Hamiltonian if and only if the Chern class of the normal bundle of the vector field and Bott class of the transversally holomorphic complex codimension one foliation defined by the vector field vanishes.
Yazar
Melike Işim Efe
Bu Yayına Nasıl Atıf Yapılır
Melike Işim Efe (Doctorate thesis). Global bi-Hamiltonian structure of three dimensional dynamical systems, 2016, Yeditepe University.
Anahtar Kelimeler
Lisans
Tüm Hakları Saklıdır
Bu eser belirtilen lisans koşulları altında paylaşılmaktadır.
Yeditepe University tezlerinden daha fazlası
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)